On September 24th the European Head and Neck Society (EHNS) and the European Cancer Patient Coalition (ECPC) will join forces with the European Parliament to highlight the challenges in treating head and neck cancer...
News from the Journal of AIDS, Oct. issue
9/24/2013
Early changes of AIDS-related lymphoma; new approaches to promote circumcision to reduce HIV risk; updates on HIV lifetime costs of care and quality of life estimates JAIDS: Journal of Acquired Immune Deficiency Syndromes announced its research article highlights from the October issue now available on the journal website. The journal is published by Wolters Kluwer Health...
New method for analyzing gene expression in single cells opens window into tumors and other tissues
9/24/2013
A team of researchers affiliated with Ludwig Cancer Research and the Karolinska Institutet in Sweden report in the current issue of Nature Methods a dramatically improved technique for analyzing the genes expressed within a single cell -- a capability of relevance to everything from basic research to future cancer diagnostics...
Protein that regulates cellular trafficking offers potential for anti-cancer therapy
9/24/2013
Molecular microbiologists at the University of Southern California (USC) have uncovered intricate regulatory mechanisms within the cell that could lead to novel therapeutics for the treatment of cancer and other diseases. Their findings, which have long-standing significance in the basic understanding of cell biology, appear in the journal Nature Cell Biology...
A clear look at a crucial step in cancer metastasis
9/24/2013
Cancer cells metastasize in several stages -- first by invading surrounding tissue, then by infiltrating and spreading via the circulatory system. Some circulating cells work their way out of the vascular network, eventually forming a secondary tumor...
Switch identified that controls growth of most aggressive brain tumor cells
9/24/2013
Researchers at UT Southwestern Medical Center have identified a cellular switch that potentially can be turned off and on to slow down, and eventually inhibit the growth of the most commonly diagnosed and aggressive malignant brain tumor. Findings of their investigation show that the protein RIP1 acts as a mediator of brain tumor cell survival, either protecting or destroying cells...
News from the Journal of AIDS, Oct. issue
9/24/2013
Early changes of AIDS-related lymphoma; new approaches to promote circumcision to reduce HIV risk; updates on HIV lifetime costs of care and quality of life estimates JAIDS: Journal of Acquired Immune Deficiency Syndromes announced its research article highlights from the October issue now available on the journal website. The journal is published by Wolters Kluwer Health...
Dog food preservative may thwart pain and damage of peripheral neuropathy
9/24/2013
Working with cells in test tubes and in mice, researchers at Johns Hopkins have discovered that a chemical commonly used as a dog food preservative may prevent the kind of painful nerve damage found in the hands and feet of four out of five cancer patients taking the chemotherapy drug Taxol...
Biomarker identified for smoker's lung cancer
9/23/2013
Mayo Clinic researchers have shown that a specific protein pair may be a successful prognostic biomarker for identifying smoking-related lung cancers. The protein - ASCL1 - is associated with increased expression of the RET oncogene, a particular cancer-causing gene called RET. The findings appear in the online issue of the journal Oncogene...
Missing immune response may prove a vital link for new leukaemia treatments
9/23/2013
Patients suffering from leukaemia could have their immune system engineered to fight the disease, after scientists at the University of Birmingham discovered that they lacked an immune response to a certain class of proteins which could be restored through stem cell transplants...